The European Parliament has given the thumbs up to the first ever Europe-wide public–private research partnerships, approving programmes in miniaturisation, embedded computers, medicines and aviation.
Most of the Cohesion Policy budget of €347 million is being invested in projects that support the Lisbon strategy, according to the latest analysis of the programme.
Private equity firm Celtic Pharma is launching two new funds worth $1.5 billion in total, to invest in development-stage biotech companies and products.
The spin-out tag makes university start-ups look weak and vulnerable, says Philip Sharpe from QinetiQ, one of Europe’s largest technology commercialisation companies.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.